Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
CareCloud and ChartSwap Partner to Launch "CareCloud Powered by ChartSwap" to Streamline the Request for Information Process
-
BDev Ventures Announces Strategic Investment in Personal AI
-
The Oncology Institute of Hope & Innovation Launches Oregon Market
-
Notice to General Meeting
-
Osisko Announces Agreement to Purchase Royalties on Spartan Resources’ Dalgaranga Gold Project in Western Australia
-
Sascha Pallenberg and Rikesh Shah headline the Tomorrow.Mobility congress
-
Play to earn in Etaku - where Ecchi art meets Web3 gaming
-
HPH to Hold Extraordinary General Meeting and Class Meeting On October 31, 2024
-
Management Dealing in Securities
-
Volcon CEO John Kim Shares Important Company Update
-
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners
-
Opthea to Participate in the UBS Virtual Ophthalmology Day 2024
-
Angitia Biopharmaceuticals Presents First-in-Human Data on AGA2118 for Osteoporosis at ASBMR 2024
-
Altimmune Completes Enrollment in Phase 2b IMPACT Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
-
Gaming and Leisure Properties Promotes Brandon Moore to Additional Role of President
-
ZenaTech Announces Approval to List Common Shares on the Nasdaq Capital Market
-
MariMed’s Betty’s Eddies Partners With Keep A Breast Foundation to Promote Breast Cancer Screening Education
-
Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024
-
DeFi Technologies Subsidiary Valour launches Asset-backed Ethereum Physical Staking ETP for Professional Investors on the London Stock Exchange
-
Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor
-
ZenaTech Announces Approval to List Common Shares on the Nasdaq Capital Market
-
BridgeBio Completes Enrollment of FORTIFY, Phase 3 Registrational Study of BBP-418 in Limb-girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9)
-
BrightSpring Health Services, Inc. Welcomes Dr. Steve Miller to Board of Directors
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
Adeia to Present at Upcoming Conferences on Hybrid Bonding Technology
-
Parsons to Announce Third Quarter 2024 Financial Results on October 30, 2024
-
Invesco Ltd: Form 8.3 - Learning Technologies Group PLC; Opening Position disclosure
-
Dr. Alejandro Duarte joins SEDA Expert’s Risk Management and Algorithmic Trading Expert Witness Practice
-
Global mayors exchange ideas in Hangzhou on sustainable urban development
-
Share buyback programme - week 39
-
Gilat Satellite Networks Receives Multimillion Service Contract from Leading Satellite Operator in APAC region
-
Kraig Biocraft Laboratories Leverages New Production Center for Largest Ever Batch of Spider Silk Parental Lines
-
Novellia and University of Alabama at Birmingham Study Examines Biomarker Testing Practices for Non-Small Cell Lung Cancer
-
Novo Nordisk A/S – Share repurchase programme
-
Antelope Enterprise Announces First Half 2024 Financial Results
-
Prime Medicine Unveils Strategically Focused Pipeline
-
Verizon and Vertical Bridge agree to $3.3 billion tower transaction
-
Tide Capital Sees Bullish Momentum for BTC and Altcoins Amid Fed’s Rate Cuts
-
Sable Identifies Cu-bearing Magmatic Hydrothermal Breccias at its Copper Queen Project in British Columbia
-
Silvaco Appoints Candace Jackson as Senior Vice President, General Counsel, and Corporate Secretary
-
BioStem Technologies, Inc. Files Form 10 with the Securities and Exchange Commission and Submits Nasdaq Application for Uplisting
-
Walden Biosciences Fully Enrolls First Cohort in Phase 2 Basket Study of WAL0921 in Chronic Kidney Diseases
-
Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the Nat
-
Nurix Therapeutics Announces Presentations at Discovery on Target Conference
-
Captivision Reports Half-Year Results for 2024
-
U.S. Government Awards BioCryst $69 Million RAPIVAB® (peramivir injection) Contract for Strategic National Stockpile
-
Mercury To Provide Upgraded Processing Power for Refueling System on U.S. Air Force’s KC-46A Tanker Fleet
-
Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer
